← Open Payments lookup

JONATHAN SADLER: Open Payments

NPI 1932738119 · PEARL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$680 in 31 payments from 10 companies in 2025. Trend: 2023 $1,032 · 2024 $1,835 · 2025 $680

Food & beverage: $680
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.7$137
Neurocrine BioSciences, Inc.5$124
E.R. Squibb & Sons, L.L.C.6$115
Alkermes, Inc.4$102
Lundbeck LLC3$63
Otsuka America Pharmaceutical, Inc.2$37
Avadel CNS Pharmaceuticals, LLC1$29
ABBVIE INC.1$28
Janssen Pharmaceuticals, Inc1$27
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17

Products named: INGREZZA, COBENFY, ARISTADA, UZEDY, ABILIFY ASIMTUFII, AUSTEDO XR, ABILIFY MAINTENA, LUMRYZ.

Industry payments across MS — which companies pay providers there.